Canada Medical Device Licensing Services
A Canadian medical-device licensing service should determine which legal permission is needed, assemble the manufacturer’s and supply-chain evidence, manage the Health Canada filing and hand over an actionable maintenance calendar. Medical Device Licence (MDL) and Medical Device Establishment Licence (MDEL) are different permissions; one does not automatically replace the other.
Which licence do you actually need?
Start with the claimed medical purpose, risk classification, identity of the label manufacturer and who will import or distribute the product. This matrix is a triage tool, not an exemption decision.
| Situation | Regulatory route | Practical service action |
|---|---|---|
| Class I device; manufacturer selling its own product | No Class I product MDL. An MDEL may be required for the manufacturer; section 44 exemptions depend on the actual distribution model. | Record intended use and Class I rationale; map buyer, importer, distributor and any MDEL exemption before shipment. |
| Class II, III or IV; original manufacturer | Manufacturer needs an MDL covering the device before ordinary import or sale; the higher classes require more substantive supporting evidence. | Confirm class, device group, model identifiers, MDSAP QMS certificate and class-specific dossier; submit MDL application. |
| Canadian importer or distributor of any class | Ordinarily requires its own MDEL unless a specific exemption applies; for Class II–IV, also verify the product MDL. | Check legal entities and supply chain, licensed device details, documented procedures and MDEL status. |
| Private-label, investigational, special-access or custom-made case | Potentially a distinct application or authorization route; do not infer that an ordinary MDL or an MDEL alone is sufficient. | Confirm ownership, intended use and applicable route before quoting or filing. |
What the licensing engagement should deliver
The core service is coordinated execution from eligibility check to post-decision handover—not merely completion of a form.
- Route memorandum: classify the actual device (including IVD where relevant), identify the legally responsible manufacturer, importers and distributors, and document the MDL/MDEL decision and unresolved assumptions.
- Gap register: compare the available QMS, labelling and technical file against the class-specific requirements, naming each missing document and the person responsible for it.
- Submission plan: allocate manufacturer declarations, clinical/performance evidence where applicable, device identifiers, fees and regulatory contacts; confirm which licence or authorization will be pursued.
- Electronic filing and questions: for MDL applications, prepare REP enrolment and send transactions via CESG; manage screening questions and information requests without promising approval or a fixed completion date.
- Handover: reconcile issued licence details and supply-chain MDEL status, verify the active MDL listing where applicable, and assign annual renewal, fee and change-control tasks.
Evidence and responsibility matrix
Collect these inputs before committing to a filing date. Availability depends on device class and application type; an item below is not automatically mandatory for every applicant.
| Input owner | Materials and decision to verify |
|---|---|
| Product / manufacturer | Intended medical use, label manufacturer, full device description, model identifiers, risk-class rationale, Canadian label and claims. |
| Quality / manufacturer | Valid ISO 13485 QMS certificate issued by an MDSAP-recognized auditing organization for Class II–IV MDL pathway; align scope and legal entity. |
| Technical / manufacturer | For the relevant risk class: evidence of safety and effectiveness, applicable tests, risk analysis, clinical or performance data where required. |
| Commercial / importer-distributor | Legal names, activities and supplier chain, licence checks, complaints/recall procedures and assignment of the establishment-licensing task. |
Government fees and timing: budget the correct route
Selected Health Canada amounts effective 1 April 2026, in CAD, excluding professional fees, audits and testing. Fees depend on the actual filing category; reductions or exemptions may apply where eligibility is proven.
| Government fee category | CAD |
|---|---|
| New Class II MDL | 643 |
| New Class III MDL (standard) | 14,163 |
| New Class III near-patient IVD MDL | 30,169 |
| New Class IV MDL | 30,713 |
| New MDEL / annual MDEL review | 5,519 |
| Annual right to sell licensed Class II–IV device | 460 |
The MDL review standards are not guaranteed market-entry deadlines. Health Canada may request further information, pause review clocks or reject an incomplete filing. Check the regulator’s current schedule before payment.
After approval: two different annual calendars
An MDL does not carry an ordinary printed expiry date, but the manufacturer must complete its annual MDL confirmation before 1 November and address the applicable right-to-sell fee. For MDEL, the establishment’s annual licence review is due before 1 April. Relevant changes can require MDL amendments or MDEL notices/amendments; a significant Class III or IV change requires review before the modified device is marketed. Maintain complaint, incident and recall procedures appropriate to the activities.
What this page covers—and what belongs elsewhere
This page owns the integrated licensing-service decision: which permissions are in scope, what each participant supplies, what the engagement delivers and what continues after approval. For a stand-alone classification/gap-analysis opinion use medical-device licensing consultant advice; for a narrow application preparation and submission mandate use MDL application filing service; for non-medical-device Canadian market-access pathways use Canadian product market-access services. None of those routes eliminates the need to test the actual device and supply chain.
Information needed to start
Provide the device description and intended use, manufacturer and label details, product class (if assessed), proposed Canadian import/distribution chain, current licences, MDSAP status, technical evidence inventory and the intended launch date. These inputs permit a scoped work plan and fee estimate—not a promise of approval.
Official primary sources
- Medical Devices Regulations
- Health Canada: MDL application guidance
- Health Canada: MDEL guidance (current effective version)
- Health Canada: REP/CESG requirement
- Health Canada: fees for 2026–2027
- Health Canada: MDSAP QMS certificate rule
- Health Canada: annual MDL renewal and change guidance
- Health Canada: MDL amendment rules
Frequently asked questions
- Can an MDEL replace the manufacturer’s Class II–IV MDL?
No. The MDL authorizes the relevant device, whereas the MDEL licenses qualifying establishment activities. An importer or distributor may need an MDEL even where the device already has an MDL.
- Does a Class I manufacturer always need an MDEL?
No automatic answer. Class I has no product MDL, but the manufacturer’s MDEL position turns on its activities and section 44 exemptions, including how it sells through licensed parties or to the ultimate consumer.
- Is EU CE marking or a general ISO 13485 certificate enough?
No automatic Canadian market permission follows. For the normal Class II–IV route, Health Canada requires an appropriate MDSAP-issued QMS certificate and the Canadian MDL; check the device-specific evidence as well.
- Can we import immediately once the electronic submission is acknowledged?
Not merely because it was submitted. Confirm that the required MDL or applicable authorization is issued and the relevant establishment activities are lawfully licensed or exempt before ordinary commercial import or sale.
- We are changing software, indications or the device name. Is a new application necessary?
It depends on the class and type of change. Section 34 defines amendment triggers; a significant Class III–IV change must be assessed before marketing the modified device. Make a documented change-impact assessment first.